A new study has revealed that anti-malaria drug Hydroxychloroquine (HCQ) has failed another test to prove its efficiency in treating treating the coronavirus COVID-19, with infected patients showing no change in their conditions after being administered HCQ.
from Zee News :World https://ift.tt/2yHBI9s
from Zee News :World https://ift.tt/2yHBI9s
